| |
|
|
|
Hemispherx Biopharma- Inc.  
|
|
0.3207 0.001 (0%) |
06-22 16:00 |
|
Open: |
0.33 |
Pre close: |
0.319606 |
Target:
|
0.39
|
|
High: |
0.33 |
Low: |
0.3126 |
Resistance:
|
0.33
0.35
|
|
Volume: |
286,482 |
Market Cap: |
15M |
Support:
|
0.30
0.25
|
|
|
|
|
|
Technical Analysis |
|
Moving Averages |
MA(5):
|
0.32
 |
MACD |
MACD(12,26):
|
-0.00 |
|
MA(20): |
0.31 |
Signal(12,26,9): |
-0.00 |
|
MA(100): |
0.39  |
Stochastic Oscillator |
%K(14,3):
|
40.47 |
|
MA(250): |
0.39 |
%D(3): |
37.93 |
|
Average Volume(K) |
3-Month: |
67293
|
52-Week |
High:
|
0.74 |
|
10-Days: |
54742 |
Low: |
0.28 |
|
RSI |
RSI(14):
|
51.82 |
Change(%): |
-37.1 |
|
Financials, Statistics and Valuation |
|
EPS |
0.000 |
Return on Equity (ttm) |
-64.7 |
Shares Out. (M) |
46.20 |
|
EPS Est. Current Year |
0.000 |
Return on Assets (ttm) |
-45.6 |
Shares Float (M) |
42.69 |
|
EPS Est. Next Year |
-0.030 |
PEG Ratio |
0.00 |
% Held by Insiders |
0.00 |
|
EPS Est. Next Quarter |
0.000 |
Qtrly Rev. Growth |
-33.3 |
% Held by Institutions |
3.30 |
|
Forward EPS |
1.#IO |
Gross Profit (p.s.) |
0.000 |
Shares Short (K) |
636 |
|
Book Value (p.s.) |
1.360 |
EBITDA (p.s.) |
0.000 |
P/E |
0.00 |
|
Sales Per Share |
0.000 |
Qtrly Earnings Growth |
0.00 |
P/BV |
0.24 |
|
Profit Margin |
0.00 |
Operating Cash Flow
(M) |
-7.49 |
P/S |
1481633920.00 |
|
Operating Margin |
-2625.43 |
Levered Free Cash Flow
(M) |
-4.94 |
P/CF |
-1.98 |
|
|
|
|
|
|
